AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 99 filers reported holding AVROBIO INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,409,536 | +110.5% | 3,512,686 | +29.9% | 0.76% | +101.9% |
| Q2 2023 | $2,570,021 | +6732.8% | 2,705,000 | +7091.7% | 0.38% | +6200.0% |
| Q1 2023 | $37,613 | -99.6% | 37,613 | -94.6% | 0.01% | -99.6% |
| Q3 2020 | $9,114,000 | -34.7% | 700,000 | -12.5% | 1.65% | +21.5% |
| Q2 2020 | $13,960,000 | -10.3% | 800,000 | -20.0% | 1.36% | -37.9% |
| Q1 2020 | $15,560,000 | -22.7% | 1,000,000 | 0.0% | 2.18% | -9.1% |
| Q4 2019 | $20,130,000 | +71.9% | 1,000,000 | +20.6% | 2.40% | +20.1% |
| Q3 2019 | $11,707,000 | – | 829,121 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |